Hat1 is the sole known example of a type B histone acetyltransferase. While it has long been presumed that type B histone acetyltransferases participate in the acetylation of newly synthesized histones during the process of chromatin assembly, definitive evidence linking these enzymes to this process has been scarce. This review will discuss recent results that have begun to shed light on the roles of Hat1 and also address several outstanding questions relating to the cellular function of this enzyme.
Although, as its name implies, Hat1 was the first histone acetyltransferase identified, it remains, in many ways, one of the most poorly understood members of this family of enzymes. This is despite the fact that the biochemical characterization of Hat1 has been fairly extensive. However, progress in our understanding of this enzyme has begun to accelerate, and this review will summarize recent advances with regard to Hat1 and address several important questions that remain to be fully resolved. In this review, proteins will be referred to with the format Hat1, while the corresponding gene will have the format HAT1.
Hat1 is the sole representative of the type B histone acetyltransferases. Type B histone acetyltransferases are distinguished by their substrate specificity and subcellular localization. Type A histone acetyltransferases possess the properties normally associated with chromatin-modifying enzymes as they are localized to the nucleus and are capable of modifying histones that are incorporated into chromatin. An extensive series of biochemical fractionation studies identified type B histone acetyltransferases as a distinct class of enzymes that can be found in the cytoplasm and, most importantly, have the ability to acetylate free, but not nucleosomal, histones (Garcea and Alberts, 1980; Sures and Gallwitz, 1980; Wiegand and Brutlag, 1981; Richman et al., 1988; Lopez-Rodas et al., 1991a, b; Mingarro et al., 1993; Brownell and Allis, 1996) . Therefore, these enzymes likely modify histones before their assembly into chromatin rather than directly acting on preexiting chromatin structures. These properties of type B histone acetyltransferases make them the obvious candidates for the acetylation of newly synthesized histones H3 and H4. Histones H3 and H4 are rapidly acetylated following their synthesis (Louie et al., 1974; Ruiz-Carillo et al., 1975; Jackson et al., 1976) . These modifications are then removed after the assembly of the histones into nucleosomes during the process of chromatin maturation (Jackson et al., 1976; Annunziato and Seale, 1983) . For histone H4, acetylation of newly synthesized molecules occurs in a specific pattern that appears to be highly conserved throughout eukaryotes. Of the lysine residues in the histone H4 N-terminal tail that are subject to acetylation (lysines 5, 8, 12 and 16) , analysis of newly synthesized histone H4 from several diverse eukaryotes shows acetylation at lysines 5 and 12 (or equivalent positions) but not at 8 and 16 (Chicoine et al., 1986; Sobel et al., 1995) . For histone H3, acetylation of newly synthesized molecules has been conserved, but the specific pattern of acetylation can vary between different organisms (Sobel et al., 1995; Kuo et al., 1996; Benson et al., 2006) .
Identification of HAT1
The gene encoding HAT1 was originally identified as a histone acetyltransferase by two independent approaches. The first involved screening a collection of temperature-sensitive yeast mutants to identify a strain that had a decreased level of histone acetyltransferase activity in cell extracts. While the decreased histone acetyltransferase activity did not segregate with the temperature-sensitive phenotype, this assay allowed for the mapping and cloning of the gene responsible for the histone acetyltransferase activity (Kleff et al., 1995) . The second was a traditional biochemical approach to isolate the major histone H4-specific acetyltransferase activity found in yeast cytoplasmic extracts. Following purification to homogeneity, protein sequence data from the catalytic subunit led to the identification of the corresponding gene (Parthun et al., 1996) .
Biochemistry of Hat1
The classification of Hat1 as a type B histone acetyltransferase was based on the initial biochemical characterization of the enzyme. First, high levels of Hat1-dependent activity are found in the cytosolic fraction following lysis of yeast spheroplasts (Parthun et al., 1996) . This suggested that the enzyme is at least partially cytoplasmic or that a significant fraction of the enzyme is only loosely associated with the nucleus. Second, both recombinant Hat1 and, more importantly, the native enzyme isolated from yeast extracts is highly active on free histone substrates, but has no detectable activity on nucleosomal histones (Parthun et al., 1996) . In addition, both the recombinant and native Hat1 enzymes are very specific for histone H4 with the native enzyme capable of modifying H4 lysine 12 and the recombinant enzyme acting at both lysines 5 and 12 (as well as a minor activity on histone H2A) (Kleff et al., 1995; Parthun et al., 1996) . This specificity is entirely consistent with the pattern of acetylation found on newly synthesized histone H4.
Hat1 isolated from yeast cytosolic extracts copurifies with a second polypeptide-designated Hat2 (Parthun et al., 1996) . Hat2 is a WD40 repeat protein that is a yeast homologue of the mammalian Rbap46/48 proteins which are components of a wide variety of chromatinmodifying complexes (Qian et al., 1993; Qian and Lee, 1995; Taunton et al., 1996; Verreault et al., 1996; Hassig et al., 1997; Zhang et al., 1997 Zhang et al., , 1999 Martinez-Balbas et al., 1998; Wade et al., 1998; Xue et al., 1998) . The association of Hat2 with Hat1 increases the catalytic activity of the enzyme by a factor of ten and appears to function by increasing the interaction between Hat1 and histone H4 (Parthun et al., 1996) . In addition, Rbap46 and Rbap48 have both been shown to bind histone H4 directly through contacts with the a-helix immediately proximal to the N-terminal tail (Verreault et al., 1998; Vermaak et al., 1999; Furuyama et al., 2006) . Masking of this helix following assembly of histone H4 into chromatin may be an important factor in the inability of the Hat1/Hat2 complex to modify nucleosomal substrates. The purification of type B histone acetyltransferase activities from several other organisms demonstrates that the composition of histone H4-specific type B histone acetyltransferase complexes is evolutionarily conserved. Type B histone acetyltransferase activities purified from human, Xenopus laevis and maize extracts all contain a catalytic subunit similar to Hat1 and a second subunit similar to Hat2 (Rbap46 in human cells and Rbap48 in X. laevis) (Eberharter et al., 1996; Chang et al., 1997; Verreault et al., 1998; Imhof and Wolffe, 1999; Lusser et al., 1999) . In addition, the chicken homologue of Hat1 interacts with the chicken homologue of Rbap48 (Ahmad et al., 2000 (Ahmad et al., , 2001 . These results indicate that the Hat1/Hat2 complex constitutes the conserved core of the H4-specific type B histone acetyltransferase (often referred to as the HAT-B complex).
In addition to having a conserved subunit composition, the human and X. laevis type B histone acetyltransferase complexes also share the substrate specificity of their yeast counterpart. Native complexes from human and X. laevis only acetylate free histones and are capable of acetylating histone H4 at lysines 5 and 12 (Chang et al., 1997; Verreault et al., 1998; Imhof and Wolffe, 1999) . In addition, human Hat1 also displays a minor activity on histone H2A lysine 5 (Chang et al., 1997; Verreault et al., 1998) . Taken together, the high level of similarity, both in terms of subunit composition and substrate specificity, displayed by H4-specific type B histone acetyltransferases from a diverse group of eukaryotes indicates that these enzymes may be as highly conserved throughout evolution as the pattern of acetylation found on newly synthesized histone H4.
Our biochemical understanding of Hat1 has been greatly enhanced by the availability of a high-resolution crystal structure of the yeast enzyme in a complex with acetyl-coenzyme A (Ac-CoA) (Dutnall et al., 1998) . Overall, the enzyme adopts a curved structure (picture a wedge from an orange) with the N-and C-termini at opposite ends. The active site of the enzyme is found near the center of the concave surface of the protein.
The location of the active site is indicated by the presence of Ac-CoA that binds in a cleft in this region. Surprisingly, although there is very minimal primary sequence similarity between Hat1 and other histone acetyltransferases, comparison of the Hat1 structure with those of the type A histone acetyltransferases P/CAF and ESA1 showed that the active sites of these three enzymes have a remarkably conserved structure. This structural similarity includes a glutamic acid residue (E255 in Hat1) that is positioned to act as a catalytic base and that has been shown to be essential for the enzymatic activity of P/CAF and Esa1 (Smith et al., 1998; Trievel et al., 1999; Yan et al., 2000) .
The crystal structure of Hat1 also provides a structural foundation for the observed sequence specificity of Hat1. Based on the ability of yeast Hat1 to acetylate specific residues in histones isolated from a variety of organisms, it was proposed that the activity of yeast Hat1 is targeted to specific lysines through binding to a recognition motif of GXGKXG (where X is any amino acid) (Parthun et al., 1996) . Through modeling of a peptide encompassing the N terminus of histone H4 (using an extended structure for the histone peptide), Dutnall et al. (1998) demonstrated that the e-NH 2 -group of H4 lysine 12 can approach the carbonyl group of Ac-CoA if the H4 tail peptide binds across a surface of Hat1 such that it is roughly perpendicular to the long axis of Hat1. Interestingly, the contours of this surface are highly compatible with the proposed recognition motif for Hat1. For example, the length of this surface can accommodate six to seven amino acids in good agreement with the length of the recognition motif. In addition, the glycine residues that flank the lysine are positioned over the shallowest part of the surface, while the leucine residue at position 10 is positioned over a hydrophobic pocket (Dutnall et al., 1998) .
The structure of the Hat1 active site also predicted another interesting aspect of substrate specificity; the contribution of the lysine residues at positions 8 and 16. In the modeling studies, these residues become juxtaposed to two acidic patches on either side of the active site suggesting that positive charge at these positions stabilize binding of the H4 tail to Hat1. Two recent reports from the Annunziato laboratory have confirmed this prediction. Using Hat1 from both yeast and human, it was demonstrated that acetylation of synthetic peptides on lysines 8 and 16 eliminates the ability of Hat1 to modify the peptides (Makowski et al., 2001 ). In addition, peptides containing arginine residues substituted for the lysines at 8 and 16 are completely competent as substrates for Hat1 indicating that positive charge at these positions, and not the specific presence of a lysine residue, is important for substrate binding to Hat1 (Benson et al., 2007) . These results are an important example of how a histone post-translational modification can influence the activity of enzymes that act on nearby residues.
While the biochemical characterization of type B histone acetyltransferases progressed rapidly following the identification of Hat1, our knowledge of the cellular function of this class of enzymes is still quite rudimentary. There are a number of critical questions that must be addressed before the in vivo role of type B histone acetyltransferases is fully elucidated.
Are type B histone acetyltransferases cytoplasmic or nuclear?
Cytoplasmic localization was one of the original defining characteristics of type B histone acetyltransferases. But are these enzymes really cytoplasmic? The idea that type B histone acetyltransferases are located in the cytoplasm arose from the fact that histone acetyltransferase activities, usually specific for free histone H4, are found in the soluble fraction following lysis of a variety of eukaryotic cell types. However, the fact that a protein does not pellet with nuclei does not necessarily mean that it was not nuclear before cell lysis as many proteins have been shown to leak out of isolated nuclei (Li and Kelly, 1984; Decker et al., 1987) . The identification of Hat1 as a type B histone acetyltransferase provided the tools to more definitively determine the subcellular localization of this enzyme.
In Saccharomyces cerevisiae, evidence from a variety of different experiments suggests that the enzyme is actually both cytoplasmic and nuclear. Deletion of the gene encoding HAT1 not only eliminates the H4-specific histone acetyltransferase present in cytoplasmic extracts, but also causes the loss of an activity present in nuclear extracts as well (Parthun et al., 1996; Ruiz-Garcia et al., 1998) . Also, distinct Hat1/Hat2-containing complexes can be purified from both cytoplasmic and nuclear extracts (Ai and Parthun, 2004; Poveda et al., 2004) . Immunofluorescence results corroborate the biochemistry. Localization of native Hat2 shows a strong concentration in the nucleus with a significant staining throughout the cytoplasm as well (Ai and Parthun, 2004) . Localization of epitope-tagged Hat1 and Hat2 (expressed from their native promoters) shows a similar pattern with dense staining in nuclei and diffuse staining in the cytoplasm (Poveda et al., 2004) . Interestingly, the nuclear localization of Hat1 is dependent on the presence of HAT2 (Poveda et al., 2004) . While it is difficult to accurately determine the relative proportions of a protein in different cellular compartments based on indirect immunofluorescent images, it seems likely that the majority of yeast Hat1-containing complexes are actually in the nucleus.
A similar situation also exists in more complex eukaryotes. Visualization of epitope-tagged human and chicken Hat1 shows that the enzyme is largely nuclear with a weak cytoplasmic staining as well (Verreault et al., 1998; Ahmad et al., 2001) . In maize, cytoplasmic extracts contain the majority of Hat1-dependent activity, but immunofluorescent analysis of isolated nuclei show a significant level of Hat1 as well (Lusser et al., 1999) .
The most thorough characterization of Hat1 subcellular localization was performed in X. laevis (Imhof and Wolffe, 1999) . Nuclei can be manually dissected out of X. laevis oocytes allowing for the generation of unambiguous extracts. Results using this technique show that the vast majority of Hat1 is nuclear in oocytes. Interesting, the overall level of Hat1 in oocytes is approximately 1000 times greater than in somatic cells suggesting that Hat1 may be playing a specialized role in these cells. While Hat1 is largely nuclear in oocytes, its subcellular localization changes dramatically during development. Hat1 redistributes to become largely cytoplasmic during embryogenesis. In fully differentiated cells, Hat1 is found in both the cytoplasm and nucleus (Imhof and Wolffe, 1999) . Therefore, Hat1 subcellular localization appears to be dynamically regulated throughout development.
Taken together, the preponderance of the evidence indicates that we need to revise the model of type B histone acetyltransferases as strictly cytoplasmic enzymes. Hat1-containing complexes are clearly found in both the cytoplasm and the nucleus and, in fact, appear to be predominantly nuclear. However, as no type A histone acetyltransferases have been shown to be in the cytoplasm, partial, but not exclusive, localization to the cytoplasm is still valid as a distinguishing characteristic of type B histone acetyltransferases. A number of issues relative to the subcellular localization of Hat1 remain to be addressed. For example, it is not known whether the dual localization of Hat1 is a reflection of whether the enzyme actively shuttles between the nucleus and the cytoplasm. In addition, the importance of Hat1's localization to the in vivo function of the enzyme remains to be determined.
Is Hat1 responsible for the acetylation of newly synthesized histone H4?
The biochemical properties of Hat1 perfectly match those that would be predicted for the enzyme involved in the acetylation of newly synthesized histone H4. Surprisingly, it has not been definitively demonstrated that Hat1 is actually involved in this process. Therefore, to try to address this issue, the question will be broken down into parts.
The first part of the question is whether Hat1 is involved in the acetylation of histone H4 in vivo. As described above, Hat1 enzymes from a wide variety of eukaryotes have a remarkably conserved specificity for histone H4 lysines 5 and 12 when assayed in vitro. However, in vitro assays are not necessarily accurate indicators of in vivo enzyme specificity. In fact, hat1D mutants in S. cerevisiae have normal levels of histone H4 lysine 12 acetylation (Poveda et al., 2004) . The lack of a defect in steady-state levels of histone H4 acetylation in the absence of HAT1 may not be surprising given the transient nature of the acetylation event that occurs on newly synthesized histone H4.
Evidence indicating that Hat1 does, in fact, acetylate histone H4 in vivo comes from a number of molecular genetic studies in yeast. Deletion of the HAT1 gene in budding yeast results in no observable phenotypes (Kleff et al., 1995; Parthun et al., 1996) . However, combining mutations in specific lysine residues (changed to arginine) in the histone H3 N-terminal tail with a deletion of HAT1 results in defects in telomeric silencing and the recombinational repair of DNA double-strand breaks (Kelly et al., 2000; Qin and Parthun, 2002) . These phenotypes have provided an opportunity to test whether Hat1 functions through the acetylation of histone H4 in the contexts of heterochromatin assembly and DNA repair. For the case of telomeric silencing, evidence that Hat1 influences telomeric chromatin structure through the acetylation of histone H4 is provided by the observation that combining the histone H3 N-terminal tail mutations with a histone H4 lysine 12 to arginine mutation phenocopies the deletion of HAT1. Hat1 appears to act specifically through H4 lysine 12 as the mutation of lysines 5, 8 or 16 does not result in a similar telomeric-silencing defect (Kelly et al., 2000) .
More direct evidence for the in vivo acetylation of histone H4 lysine 12 by yeast Hat1 comes from the characterization of chromatin structure near the site of a DNA double-strand break. Following induction of the endonuclease HO, a single double-strand break is introduced in the yeast genome at the site of the MAT locus. Chromatin immunoprecipitation analysis has shown that the presence of this double-strand break induces an increase in the level of acetylation at all four lysines in the histone H4 N-terminal tail in the vicinity of the double-strand break. Importantly, Hat1, which is recruited to chromatin at the site of a DNA doublestrand break, is specifically required for the increase in acetylation of histone H4 lysine 12 (Qin and Parthun, 2006) . Hence, in the contexts of both telomeric silencing and DNA repair, it appears that Hat1 is functioning through the acetylation of histone H4 lysine 12. This in vivo specificity perfectly matches the specificity of the native Hat1/Hat2 complex isolated from yeast.
The accumulated data indicates that Hat1 does acetylate histone H4 in the cell. The second part of this question is whether this Hat1-dependent acetylation occurs on the population of newly synthesized molecules. The standard method for characterizing newly synthesized histones is to use a pulse-chase experiment (using radiolabeled acetate or lysine) followed by visualization on triton-acid-urea gels and/or identification of the sites of radiolabeled acetyl lysine by N-terminal sequence analysis (Chicoine et al., 1986; Sobel et al., 1994 Sobel et al., , 1995 Kuo et al., 1996; Benson et al., 2006) . This experiment is straightforward in higher eukaryotes where it is relatively easy to rapidly isolate highly purified histones. However, in the more genetically tractable organism S. cerevisiae, where HAT1 mutants have been most extensively characterized, difficulties in obtaining highly purified histones have prevented an assessment of the effect that loss of Hat1 has on the population of newly synthesized histone H4.
The most compelling evidence in yeast for a role for Hat1 in the acetylation of newly synthesized histones comes from coimmunoprecipitation experiments with protein A-tagged histone H4. When the epitope-tagged histone H4 is affinity purified from yeast cytoplasmic extracts, the major proteins associating with it were a karyopherin (Kap123) and Hat1 and Hat2 (Mosammaparast et al., 2002). While, as described above, the use of cell fractionation experiments cannot unambiguously determine where in the cell a protein complex is localized, the association of histone H4 with a nuclear import factor strongly suggests that this extract contains histone H4 molecules that are in the process of transit to the nucleus. Hence, the most straightforward interpretation of this result is that the Hat1/Hat2 complex can physically interact with histone H4 before its import into the nucleus consistent with the enzyme acting on newly synthesized molecules.
Data from chicken tissue culture cells also suggests that Hat1 is involved in the acetylation of newly synthesized histone H4. Chicken DT40 cells with a homozygous HAT1 deletion showed a moderate decrease in histone H4 lysine 5 and 12 acetylation specifically in the pool of soluble histones (Barman et al., 2006) . However, pulse-labeling experiments will need to be done to confirm that the effect of the HAT1 deletion is actually on the newly synthesized molecules rather than on mature histones that have been displaced from chromatin. The retention of significant levels of H4 lysine 5 and 12 acetylation in this soluble histone fraction also suggests that Hat1 may not be the only enzyme involved in the acetylation of newly synthesized histone H4 in these cells.
While none of these results are definitive, most of the data concerning the in vivo substrates of Hat1 are consistent with Hat1 acting on histone H4 lysines 5 and/ or 12 and consistent with these histones representing the newly synthesized fraction.
Does Hat1 function in the process of chromatin assembly in vivo?
Based on the temporal correlation between the acetylation of newly synthesized histones H3 and H4 at the beginning of the chromatin assembly process and their deacetylation at the completion of chromatin assembly, it has been widely presumed that this cycle of acetylation and deacetylation plays a role in de novo histone deposition (Annunziato and Hansen, 2000) . However, the in vivo characterization of Hat1 function has been problematic and the answer to this question is only beginning to be answered.
The difficulty in uncovering the cellular function of Hat1 is largely due to the surprising observation that neither the highly conserved pattern of acetylation on newly synthesized histone H4 nor the equally wellconserved Hat1/Hat2 complex is necessary for viability in yeast (Megee et al., 1990; Kleff et al., 1995; Parthun et al., 1996; . HAT1 has been genetically deleted from two other cell types, S. pombe and chicken DT40 cells, and it is also not essential for viability in either (Barman et al., 2006; Benson et al., 2007) . As chromatin assembly is necessary for viability, Hat1 is clearly not essential for this process.
The problem in observing a defect in either chromatin assembly or viability in the absence of Hat1 may be due to redundancies built in to process of chromatin assembly. This appears to be particularly true in S. cerevisiae where numerous factors involved in the assembly of chromatin, such as the CAF-1 complex, Asf1 and the Hir proteins, are not essential for viability suggesting that there are multiple chromatin assembly pathways (both replication-coupled and replication independent) that can compensate for each other Akey and Luger, 2003; Loyola and Almouzni, 2004) . A second source of redundancy may be the presence of additional histone acetyltransferases that can target newly synthesized histone H4 in the absence of Hat1. The observation that loss of Hat1 does not abolish acetylation of histone H4 lysines 5 and 12 in either S. cerevisiae or chicken DT40 cells is consistent with this possibility (Poveda et al., 2004; Barman et al., 2006) . A third source of redundancy that could mask the cellular role of Hat1 is potential overlap in function between the acetylation of newly synthesized histones H3 and H4. This idea is strongly supported by the fact that the phenotypes associated with deletion of Hat1 in budding yeast are only manifested in the presence of mutations that also prevent the acetylation of specific lysine residues in the H3 N-terminal tail (Kelly et al., 2000; Qin and Parthun, 2002) .
While Hat1 is clearly not essential for viability, the spectrum of phenotypes observed in the absence of HAT1 is consistent with a role for this protein in chromatin assembly. For example, telomeric silencing has proven to be a very sensitive assay for alterations in chromatin structure with numerous chromatin-modifying activities involved in maintaining the transcriptionally repressed nature of normal telomeres. Among these are a number of histone chaperones involved in chromatin assembly such as CAF-1, Asf1 and Hir2/ Hir3 (Enomoto et al., 1997; Kaufman et al., 1997 Kaufman et al., , 1998 Le et al., 1997; Enomoto and Berman, 1998; Singer et al., 1998; Meijsing and Ehrenhofer-Murray, 2001; Sharp et al., 2001; Krawitz et al., 2002) .
The defect in the recombinational repair of DNA double-strand breaks may also be a reflection of a defect in chromatin assembly. Chromatin assembly is likely to be an important aspect of the DNA repair process as many DNA repair mechanisms require extensive new DNA synthesis that must be followed by chromatin assembly to restore the DNA to its normal state (Green and Almouzni, 2002) . This is supported by the observation that cells lacking histone chaperones, such as CAF-1 and Asf1, are sensitive to specific types of DNA damage (Kaufman et al., 1997; Tyler et al., 1999) . In addition, the CAF-1 complex has been shown to directly participate in the process of nucleotide excision repair (Gaillard et al., 1996 (Gaillard et al., , 1997 . Therefore, the sensitivity to DNA damage of cells lacking HAT1, which is an evolutionarily conserved phenotype that is also observed in S. pombe and chicken DT40 cells, is consistent with a role for this enzyme in the chromatin assembly that occurs in conjunction with recombinational DNA repair (Barman et al., 2006; Benson et al., 2007) .
There are additional genetic interactions that could potentially link Hat1 to chromatin assembly. The generation of a collection containing the complete set of yeast nonessential gene deletions has facilitated large-scale screens to identify genes that show synthetic genetic interactions. Screens of this type have found that both HAT1 and HAT2 mutants show either synthetic lethality or synthetic growth defects with multiple components of the origin recognition complex and CDC45 (Suter et al., 2004; Tong et al., 2004) . As these factors are essential for the initiation of DNA replication, these results suggest that there may be an essential link between DNA replication and chromatin assembly. Alternatively, the Hat1/Hat2 complex may have an unanticipated role in the modulation of chromatin structure that accompanies the initiation of DNA replication (Vogelauer et al., 2002) .
The most convincing evidence in support of a role for Hat1 in chromatin assembly derives from the characterization of the nuclear Hat1/Hat2 complex in S. cerevisiae. When purified from nuclei, the Hat1/Hat2 complex is associated with an additional factor, Hif1 (Hat1 interacting factor 1) (Ai and Parthun, 2004; Poveda et al., 2004) . In order to distinguish between the nuclear and cytoplasmic Hat1-containing complexes, the nuclear Hat1 complex will be referred to as the NuB4 complex (nuclear type B histone acetyltransferase specific for H4) based on the nomenclature used for the NuA3 and NuA4 complexes which are nuclear type A histone acetyltransferase complexes specific for histones H3 and H4, respectively (Allard et al., 1999; John et al., 2000) . In addition to biochemical cofractionation, genetic evidence also indicates that Hif1 functions with the Hat1/Hat2 complex in the cell (Ai and Parthun, 2004; Poveda et al., 2004 ). Based on a low level of sequence similarity to the X. laevis histone chaperone N1, Hif1 was shown to be a histone H3/H4-specific chaperone that also displays chromatin assembly activity in vitro. Interestingly, the in vitro chromatin assembly activity of Hif1 requires an additional factor (as yet unidentified) present in yeast cytosolic extracts. These observations were corroborated by the fact that the native NuB4 complex is associated with histones H3 and H4 in the cell. Interestingly, the in vivo interaction between Hif1 and histones is dependent on the presence of Hat1 and Hat2 (Ai and Parthun, 2004; Poveda et al., 2004) . Therefore, the NuB4 complex provides a direct connection between Hat1 and histone deposition through a physical interaction between this enzyme and a histone chaperone with chromatin assembly activity. This connection may extend to higher eukaryotes, as the human homologues of all three components of this complex copurify with multiple human histone H3 variants (Tagami et al., 2004) .
The nuclear X. laevis Hat1/Rbap48 complex also copurifies with an additional factor; a 14-3-3 protein.
The functional relevance of this association is not clear, but it is interesting to note that 14-3-3 proteins have also been shown to have histone-binding activity (Macdonald et al., 2005) .
While many issues concerning the function of Hat1 remain unresolved, a working model is emerging to describe the activity of Hat1 in the cell (Figure 1 ). The available evidence suggests that the Hat1/Hat2 complex binds to and acetylates newly synthesized histone H4 in the cytoplasm. The Hat1/Hat2 complex does not appear then to release its substrate, as most enzymes do, but remains associated with histone H4. At some point in the cytoplasm, newly synthesized histone H3 also becomes associated with the Hat1/Hat2/H4 complex. Whether this occurs before or after the acetylation of histone H4 remains to be determined. As the NuB4 complex is also stably associated with histones H3/H4 in the nucleus, the Hat1/Hat2 complex may be imported into the nucleus in association with the histones. Whether their acetylation by, or association with, the Hat1/Hat2 complex plays a role in the nuclear import of histones H3 and H4 is not clear. Once in the nucleus, the Hat1/Hat2/H3/H4 complex becomes associated with the histone chaperone/chromatin assembly factor Hif1 to form the NuB4 complex. It is likely then that Hif1 functions in a chromatin assembly pathway to help deposit the histones onto DNA. Whether Hat1 and Hat2 dissociate from Hif1or whether the entire NuB4 complex participates in histone deposition is not known. Figure 1 A working model of Hat1 function. The cytoplasmic Hat1/Hat2 (Rbap46/48) complex associates with newly synthesized histone H4 in the cytoplasm. The Hat1/Hat2 complex acetylates this histone H4 on lysine residues 5 and/or 12 (denoted by *). Newly synthesized histone H3 binds with histone H4 and the entire complex is imported into the nucleus with the aid of karyopherins such as Kap123. Whether the newly synthesized histones associated with the Hat1/Hat2 complex are in the form of heterodimers or heterotetramers has not been determined. Once in the nucleus, the Hat1/Hat2 complex associates with the histone chaperone/ chromatin assembly protein Hif1 to form the NuB4 complex, which then functions in the deposition of the newly synthesized H3/H4 complex onto DNA.
Hat1 and the dynamics of newly synthesized histones MR Parthun
However, both Hat1 and Hif1 are recruited to chromatin in the vicinity of a DNA double-strand break consistent with a model in which the intact NuB4 complex functions in chromatin assembly (Qin and Parthun, 2006 ). An intriguing aspect of this model is that Hat1 may not be functioning in a strictly catalytic capacity and that it may actually physically escort histone H4 from the point at which it is synthesized to the point at which it is assembled into chromatin.
Does Hat1 have clinical relevance?
As our picture of the cellular function of Hat1 begins to come into focus, it is important to begin to ask whether this enzyme is of clinical relevance. Chromatin structure clearly plays a critical role in the regulation of most nuclear processes, and defects in chromatin-modifying activities have been linked to numerous disease states (Jiang et al., 2004; Zhang and Dent, 2005) . Given the potentially important role that Hat1 might play in the formation of chromatin structure, it is not surprising that a number of recent studies have begun to link Hat1 to a variety of clinically important conditions. Stem cells play a critical role in tissue development and regeneration. Transcriptional profiling has identified HAT1 as a gene that is upregulated in two distinct stem-cell types. Microarray comparison of the transcript profile of long-term hematopoietic stem cells (HSC) with multipotent progenitor cells showed that HAT1 is one of a small number of chromatin-related genes enriched in the HSC population (Park et al., 2002) . Likewise, HAT1 expression has also been shown to be enriched in neural stem cells in the adult mammalian brain subventricular zone (Lim et al., 2006) .
A number of studies have also begun to link Hat1 to cancer. Rats and mice that are fed a diet, that is deficient in the sources of methyl groups, develop hepatocellular carcinomas. Pogribny et al. (2007) studied changes in a variety of epigenetic markers during the progression of the liver tumors that result from the methyl-deficient diet. They found that the spectrum of histone post-translational modifications changes during tumor progression. In addition, while several histone-modifying enzymes decrease in abundance during tumor progression, the levels of two enzymes, the histone H3 lysine 9 methyltransferase Suv39-h1 and Hat1, increase substantially in liver tumors (Pogribny et al., 2007) .
The most comprehensive study of Hat1 in cancer derived from microarray analyses aimed at identifying transcriptional targets of the Ki-ras and hepatocyte growth factor/Met signaling pathways in both colon cancer cell line and xenograft models (Seiden-Long et al., 2006) . A total of 177 unique transcripts are upregulated in the in vitro cell line and 1190 transcripts upregulated in the in vivo xenograft model. Of these, only 20 transcripts, including HAT1, are upregulated both in vitro and in vivo. Analysis of Hat1 protein levels in both the in vitro and in vivo models confirmed that Hat1 protein levels are also elevated in these cells. Importantly, further analyses indicate that HAT1 mRNA and protein levels are also elevated in primary and metastatic human colon cancer tissues. In addition, immunohistochemical staining of normal, primary and metastatic colon cancer tissue show that Hat1 is primarily nuclear in normal cells, but that there is a large increase in the cytoplasmic pool of Hat1 in the tumor tissues. Hence, the subcellular distribution of Hat1 may be an important factor in the activity of Hat1 in mammalian cells.
While still at a preliminary stage, evidence is beginning to suggest that Hat1 may play a clinically relevant role in human cells. The higher level of Hat1 seen in both stem cells and tumor cells is consistent with the proposed role for Hat1 in the process of chromatin assembly and may be a reflection of the obvious need of proliferating cells to maintain a high chromatin assembly capacity to accompany ongoing DNA replication. Future studies are needed to determine the role of Hat1 in the process of chromatin assembly in mammalian cells. If it is an integral part of this process, Hat1 may provide a novel drug target useful in halting the growth of inappropriately proliferating cells.
